Skip to main content
Retour
Watch Compare

Turn Therapeutics Inc.

Qualité des données : 83%
TTRX
Nasdaq Manufacturing Chemicals
3,50 €
0,00 € (0,00%)
Cap. Boursière: 104,26 M
Prix
3,50 €
Cap. Boursière
104,26 M
Fourchette du Jour
3,41 € — 3,50 €
Fourchette 52 Semaines
2,57 € — 26,50 €
Volume
14 362
Ouverture 3,50 €
Moyenne 50J / 200J
3,65 €
4,16% below
Moyenne 50J / 200J
4,01 €
12,77% below

Quick Summary

Points Clés

Negative free cash flow of -2,56 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-68,15%
En dessous de la moyenne du secteur (-53,41%)
ROIC-75,15%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio1,43
Interest CoverageN/A

Valorisation

PE (TTM)
-32,64
En dessous de la moyenne du secteur (-1,48)
P/B Ratio206,85
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -32,6 -1,5
P/B 206,9 1,6
ROE % -68,2 -53,4
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -3,19 M
ROE -68,15% ROA -26,26%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -2,56 M
ROIC -75,15% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,43
Interest Coverage N/A Asset Turnover N/A
Working Capital 985 486 Tangible Book Value -400 866
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -32,64 Forward P/E N/A
P/B Ratio 206,85 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -2,46%
Market Cap 104,26 M Enterprise Value 103,74 M
Per Share
EPS (Diluted TTM) -0,12 Revenue / Share N/A
FCF / Share -0,09 OCF / Share -0,09
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 80,24%
SBC-Adj. FCF -2,98 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025
Revenue —
Net Income -3,19 M
EPS (Diluted) -0,12
Gross Profit —
Operating Income -5,86 M
EBITDA —
R&D Expenses 265 570,0
SG&A Expenses —
D&A 52 746,0
Interest Expense —
Income Tax —

Balance Sheet

Annual, most recent first
Metric FY2025
Total Assets 12,16 M
Total Liabilities 7,48 M
Shareholders' Equity 4,69 M
Total Debt —
Cash & Equivalents 4,03 M
Current Assets 5,20 M
Current Liabilities 6,00 M